Quality 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic Acid Manufacturer & Supplier | NINGBO INNO PHARMCHEM

Discover high-purity 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid (CAS: 763114-26-7), a critical intermediate for developing potent PARP inhibitors and anticancer agents. Reliable manufacturer and supplier for your pharmaceutical R&D needs.

Get a Quote & Sample

Key Advantages of Partnering with Us

Exceptional Purity and Quality

We provide 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid with a minimum purity of 97%, crucial for sensitive pharmaceutical synthesis and ensuring reproducible research outcomes. Purchase with confidence from our experienced manufacturer.

Critical Pharmaceutical Intermediate

This compound is indispensable in the synthesis of phthalazinone scaffolds, vital for developing targeted therapies like PARP inhibitors. Secure your research materials by enquiring about our bulk pricing.

Secure Supply Chain

As a dedicated manufacturer in China, we offer stable and consistent supply, catering to diverse order quantities from research labs to larger production needs. Contact us for a timely quote and sample.

Primary Applications in Research

PARP Inhibitor Synthesis

Crucial for researchers developing novel inhibitors targeting poly(ADP-ribose) polymerase, a key enzyme in DNA repair and a significant target in cancer therapy. Inquire about purchase options.

Anticancer Drug Development

Serves as a fundamental intermediate in the design of isocorydine derivatives and other compounds exhibiting anticancer effects. Explore bulk purchase opportunities.

Pharmaceutical Research

A valuable building block for organic chemists and pharmaceutical scientists engaged in novel molecule synthesis and drug discovery programs. Find our competitive pricing as a trusted supplier.

Organic Synthesis

A versatile intermediate with a defined structure (C16H11FN2O3), suitable for various complex organic synthesis pathways in medicinal chemistry. Request a quote today.